• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保健支出的国际比较:我们知道什么以及我们不知道什么。

International comparisons of health care expenditures: what we know and what we do not know.

作者信息

Kanavos P, Mossialos E

机构信息

Department of Social Policy & Administration and LSE Health, London School of Economics and Political Science, London, UK.

出版信息

J Health Serv Res Policy. 1999 Apr;4(2):122-6. doi: 10.1177/135581969900400211.

DOI:10.1177/135581969900400211
PMID:10387404
Abstract

International comparisons of health care expenditures and their determinants have attracted considerable attention since the early 1960s and have since been used widely to compare countries. The impetus for this has been two-fold: firstly, to assess the macroeconomic efficiency of health systems by determining whether different methods of financing and delivering health care have contributed to the control of overall spending levels; and, secondly, to investigate the determinants of the level of health care expenditure. Empirical research has suggested that there is a causal and statistically significant relationship between growth in health spending and growth in gross domestic product (GDP), and that an increase in the latter brings about a proportionately larger increase in the former. This relationship holds even when other potential determinants, such as urbanisation and age structure of the population, are included in the analysis, leading to the conclusion that health care is a luxury good. This paper examines the extent to which this finding is valid from a methodological perspective and how far it assists policy analysis. We argue that there are significant problems in the measurement of health spending and GDP, discuss the methodological problems in the analysis and suggest that the observed relationship between GDP and health spending is unhelpful and almost certainly misleading for health policy development.

摘要

自20世纪60年代初以来,医疗保健支出及其决定因素的国际比较就备受关注,此后被广泛用于比较各国情况。这样做的动力有两方面:其一,通过确定不同的医疗保健融资和提供方式是否有助于控制总体支出水平,来评估卫生系统的宏观经济效率;其二,调查医疗保健支出水平的决定因素。实证研究表明,卫生支出增长与国内生产总值(GDP)增长之间存在因果关系且具有统计学意义,而且后者的增长会使前者出现更大比例的增长。即使在分析中纳入其他潜在决定因素,如城市化和人口年龄结构,这种关系依然成立,从而得出医疗保健是奢侈品的结论。本文从方法论角度审视这一发现的有效程度,以及它在多大程度上有助于政策分析。我们认为,在卫生支出和GDP的衡量方面存在重大问题,讨论了分析中的方法论问题,并指出观察到的GDP与卫生支出之间的关系对卫生政策制定并无帮助,而且几乎肯定会产生误导。

相似文献

1
International comparisons of health care expenditures: what we know and what we do not know.医疗保健支出的国际比较:我们知道什么以及我们不知道什么。
J Health Serv Res Policy. 1999 Apr;4(2):122-6. doi: 10.1177/135581969900400211.
2
Hong Kong domestic health spending: financial years 1989/90 to 2009/10.香港本地健康支出:1989/90 财政年度至 2009/10 财政年度。
Hong Kong Med J. 2013 Apr;19(2 Suppl 3):1-24.
3
Hong Kong domestic health spending: financial years 1989/90 to 2008/09.香港本地健康开支:1989/90 财政年度至 2008/09 财政年度。
Hong Kong Med J. 2012 Aug;18(4 Suppl 4):1-23.
4
Public financing of health in developing countries: a cross-national systematic analysis.发展中国家的卫生公共筹资:跨国系统分析。
Lancet. 2010 Apr 17;375(9723):1375-87. doi: 10.1016/S0140-6736(10)60233-4. Epub 2010 Apr 8.
5
Hong Kong domestic health spending: financial years 1989/90 to 2011/12.香港本地医疗支出:1989/90至2011/12财政年度
Hong Kong Med J. 2015 Jun;21(3 Suppl 3):1-24.
6
Hong Kong domestic health spending: financial years 1989/90 to 2010/11.香港本地健康开支:1989/90 财政年度至 2010/11 财政年度。
Hong Kong Med J. 2013 Dec;19(6 Suppl 7):1-24.
7
The relationship between health care expenditure and health outcomes. Evidence and caveats for a causal link.医疗保健支出与健康结果之间的关系。因果联系的证据与警示。
Eur J Health Econ. 2006 Mar;7(1):7-18. doi: 10.1007/s10198-005-0336-8.
8
Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.香港本地医疗开支——1989/90至2004/05财政年度。
Hong Kong Med J. 2008 Apr;14 Suppl 2:2-23.
9
Spending on medicines in Israel in an international context.以色列药品支出的国际背景。
Isr Med Assoc J. 2005 May;7(5):286-91.
10
Analysis and implications of the determinants of healthcare expenditure in African countries.非洲国家医疗保健支出决定因素的分析及影响
Health Care Manag Sci. 2005 Nov;8(4):267-76. doi: 10.1007/s10729-005-4137-5.

引用本文的文献

1
Healthcare Costs and Health-Related Quality of Life in Older Multimorbid Patients After Hospitalization.老年多病患者住院后的医疗费用及健康相关生活质量
Health Serv Insights. 2023 Feb 5;16:11786329231153278. doi: 10.1177/11786329231153278. eCollection 2023.
2
Understanding Differences in Health Care Spending: A Comparative Study of Prices and Volumes Across OECD Countries.理解医疗保健支出的差异:经合组织国家价格与数量的比较研究
Health Serv Insights. 2022 Jun 23;15:11786329221109755. doi: 10.1177/11786329221109755. eCollection 2022.
3
Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study.
结构化药物治疗评估方法对多病老年患者的成本效益:OPERAM 研究的试验内分析。
PLoS One. 2022 Apr 11;17(4):e0265507. doi: 10.1371/journal.pone.0265507. eCollection 2022.
4
Delivering a primary-level non-communicable disease programme for Syrian refugees and the host population in Jordan: a descriptive costing study.为约旦的叙利亚难民和当地居民提供初级非传染性疾病项目:一项描述性成本核算研究。
Health Policy Plan. 2020 Oct 1;35(8):931-940. doi: 10.1093/heapol/czaa050.
5
Performance of UK National Health Service compared with other high income countries: observational study.英国国民保健制度与其他高收入国家的表现比较:观察性研究。
BMJ. 2019 Nov 27;367:l6326. doi: 10.1136/bmj.l6326.
6
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study.单独或联合使用无创影像学检查诊断稳定型冠状动脉疾病的成本效益分析:EVINCI 研究结果。
Eur J Health Econ. 2019 Dec;20(9):1437-1449. doi: 10.1007/s10198-019-01096-5. Epub 2019 Aug 13.
7
The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings.在资源有限的环境中提供综合艾滋病毒和性健康及生殖健康服务的成本。
PLoS One. 2015 May 1;10(5):e0124476. doi: 10.1371/journal.pone.0124476. eCollection 2015.
8
Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions.中东和中亚国家的药品市场与卫生系统:政策与行动创新变革之时
Arch Med Sci. 2011 Jun;7(3):365-7. doi: 10.5114/aoms.2011.23397. Epub 2011 Jul 11.